Multi-Pathway Metabolic Support
What is GLP-3?
GLP-3 is an investigational triple-agonist peptide that activates the GLP-1, GIP, and glucagon receptors. It is being studied for its potential to support significant weight reduction, metabolic regulation, and insulin sensitivity.
How does GLP-3 work?
By engaging three metabolic signaling pathways, GLP-3 may help reduce appetite, improve glucose control, and increase energy expenditure — effects observed in early clinical studies.
Primary Benefits (Under Study):
-
Significant Weight-Loss Potential
-
Appetite & Craving Reduction
-
Improved Glucose & Insulin Response
-
Metabolic & Cardiovascular Marker Improvements
The Science Behind GLP-3
GLP-3 represents a multi-hormone approach to metabolic therapy, showing promising early results — but it remains non-approved and investigational, with long-term safety and durability still being evaluated.
Best for: Those exploring future metabolic therapies under clinical supervision once evidence and approvals mature.
